NanoViricides (NNVC) Short Interest Ratio & Short Volume $1.54 +0.05 (+3.36%) Closing price 04:00 PM EasternExtended Trading$1.53 -0.01 (-0.65%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NanoViricides Short Interest DataNanoViricides (NNVC) has a short interest of 70,100 shares. This marks a -46.28% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 252,755 shares to cover all short positions.Current Short Interest70,100 sharesPrevious Short Interest130,500 sharesChange Vs. Previous Month-46.28%Dollar Volume Sold Short$91.83 thousandShort Interest Ratio0.4 Days to CoverLast Record DateMay 15, 2025Outstanding Shares16,072,000 sharesPercentage of Shares Shorted0.44%Today's Trading Volume86,863 sharesAverage Trading Volume252,755 sharesToday's Volume Vs. Average34% Short Selling NanoViricides? Sign up to receive the latest short interest report for NanoViricides and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNNVC Short Interest Over TimeNNVC Days to Cover Over TimeNNVC Percentage of Float Shorted Over Time NanoViricides Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202570,100 shares $91.83 thousand -46.3%N/A0.4 $1.31 4/30/2025130,500 shares $178.79 thousand -60.6%N/A0.8 $1.37 4/15/2025330,900 shares $440.10 thousand +127.4%N/A1.6 $1.33 3/14/2025193,600 shares $238.13 thousand +37.7%N/A0.5 $1.23 2/14/2025140,900 shares $190.22 thousand -32.8%N/A0.4 $1.35 1/31/2025209,800 shares $251.76 thousand +14.1%N/A0.6 $1.20 1/15/2025183,900 shares $220.68 thousand +28.1%N/A0.6 $1.20 5/15/2023323,800 shares $0.00 -21.0%2.9%7.6 $0.00 4/30/2023410,100 shares $0.00 +16.4%3.7%9.5 $0.00 4/15/2023352,400 shares $412.31 thousand +42.4%3.2%8.4 $1.17 Get the Latest News and Ratings for NNVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. 3/31/2023247,400 shares $0.00 +34.6%2.2%7.5 $0.00 3/15/2023183,800 shares $0.00 +103.5%1.7%6.4 $0.00 2/28/202390,300 shares $0.00 -3.3%0.8%2.7 $0.00 2/15/202393,400 shares $0.00 +0.7%0.8%2.7 $0.00 1/31/202392,800 shares $0.00 -0.3%0.8%2.9 $0.00 1/15/202393,100 shares $0.00 -17.1%0.8%2.8 $0.00 12/30/2022112,300 shares $0.00 -1.0%1.0%3.2 $0.00 12/15/2022113,400 shares $0.00 -9.8%1.0%3.7 $0.00 11/30/2022125,700 shares $0.00 -17.9%1.1%3.6 $0.00 11/15/2022153,100 shares $0.00 -10.2%1.4%4.3 $0.00 10/31/2022170,500 shares $0.00 +7.2%1.5%2.5 $0.00 10/15/2022159,100 shares $0.00 +0.5%1.4%0.3 $0.00 9/30/2022158,300 shares $0.00 -2.0%1.4%0.3 $0.00 9/15/2022161,500 shares $0.00 -15.5%1.5%0.3 $0.00 8/31/2022191,100 shares $0.00 -22.0%1.7%0.3 $0.00 8/15/2022244,900 shares $0.00 +43.6%2.2%0.4 $0.00 7/31/2022170,600 shares $0.00 -10.5%1.6%0.3 $0.00 7/15/2022190,700 shares $0.00 -30.9%1.7%2.8 $0.00 6/30/2022275,800 shares $0.00 -21.9%2.5%4.2 $0.00 6/15/2022353,000 shares $0.00 -19.0%3.2%5.2 $0.00 5/31/2022435,700 shares $0.00 +116.2%4.0%6.2 $0.00 5/15/2022201,500 shares $0.00 -1.9%1.8%3.1 $0.00 4/30/2022205,300 shares $0.00 +1.4%1.9%6.1 $0.00 4/15/2022202,400 shares $0.00 +6.4%1.9%4.9 $0.00 3/31/2022190,300 shares $0.00 +24.4%1.7%4.2 $0.00 3/15/2022153,000 shares $0.00 -7.8%1.4%2.3 $0.00 2/28/2022166,000 shares $0.00 -3.8%1.5%2 $0.00 2/15/2022172,600 shares $0.00 -6.5%1.6%1.7 $0.00 1/31/2022184,600 shares $0.00 -26.2%1.7%1.4 $0.00 1/15/2022250,000 shares $0.00 -3.3%2.3%1.6 $0.00A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 12/31/2021258,400 shares $0.00 -17.2%2.4%1.3 $0.00 12/15/2021312,200 shares $0.00 -5.2%2.9%1.2 $0.00 11/30/2021329,300 shares $0.00 +11.4%3.0%0.1 $0.00 11/15/2021295,600 shares $0.00 -40.2%2.7%0.1 $0.00 10/29/2021494,500 shares $2.34 million -36.4%4.5%0.2 $4.74 10/15/2021777,000 shares $0.00 -23.1%7.1%0.3 $0.00 9/30/20211,010,000 shares $0.00 +84.1%9.7%0.4 $0.00 9/15/2021548,500 shares $0.00 +24.4%5.3%0.2 $0.00 8/31/2021441,100 shares $0.00 -40.7%4.3%1.1 $0.00 8/13/2021744,200 shares $0.00 -20.1%7.2%2 $0.00 7/30/2021931,600 shares $0.00 +29.6%9.0%2.5 $0.00 7/15/2021718,600 shares $0.00 -5.5%6.9%7.1 $0.00 6/30/2021760,300 shares $0.00 +0.0%7.3%8.2 $0.00 6/15/2021760,000 shares $0.00 -5.7%7.3%6.4 $0.00 5/28/2021805,700 shares $0.00 -4.4%7.8%6 $0.00 5/14/2021843,100 shares $0.00 -0.4%8.2%0.4 $0.00 4/30/2021846,800 shares $0.00 -14.4%8.9%0.4 $0.00 4/15/2021988,900 shares $3.86 million -1.1%10.3%0.4 $3.90 3/31/20211,000,000 shares $4.30 million -10.7%10.5%0.4 $4.30 3/15/20211,120,000 shares $4.87 million +76.9%11.7%0.4 $4.35 2/26/2021633,000 shares $2.90 million -2.5%6.6%0.3 $4.58 2/12/2021649,300 shares $3.38 million +1.2%6.8%1.9 $5.20 1/29/2021641,700 shares $2.84 million -7.4%6.7%2 $4.43 1/15/2021692,700 shares $3.61 million -0.7%7.3%2.6 $5.21 12/31/2020697,300 shares $2.15 million -8.3%7.3%3.9 $3.08 12/15/2020760,600 shares $2.72 million +0.0%8.0%4.7 $3.58 11/30/2020760,300 shares $2.74 million +14.7%8.0%3.8 $3.60 11/15/2020662,700 shares $2.33 million -10.1%6.9%1.1 $3.51 10/30/2020737,200 shares $2.76 million -5.1%7.7%1.2 $3.75 10/15/2020776,800 shares $3.01 million +3.7%8.1%1.1 $3.88 9/30/2020748,800 shares $2.88 million +18.1%7.8%0.9 $3.84 9/15/2020634,200 shares $2.42 million +28.5%6.6%0.4 $3.82 8/31/2020493,400 shares $1.96 million -28.4%5.2%0.3 $3.98 8/14/2020688,700 shares $2.70 million -2.4%7.2%0.6 $3.92 7/31/2020705,300 shares $3.98 million +4.8%7.4%0.5 $5.65 7/15/2020673,000 shares $4.20 million +65.7%7.1%0.5 $6.24 6/30/2020406,200 shares $2.59 million +56.5%5.1%0.3 $6.38 6/15/2020259,600 shares $1.85 million -14.6%3.3%0.3 $7.12 NNVC Short Interest - Frequently Asked Questions What is NanoViricides' current short interest? Short interest is the volume of NanoViricides shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 70,100 shares of NNVC short. Learn More on NanoViricides' current short interest. Is NanoViricides' short interest increasing or decreasing? NanoViricides saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 70,100 shares, a decline of 46.3% from the previous total of 130,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NanoViricides' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NanoViricides: Black Diamond Therapeutics, Inc. (15.67%), Neumora Therapeutics, Inc. (20.95%), Atossa Therapeutics, Inc. (6.14%), Procaps Group S.A. (0.12%), Sagimet Biosciences Inc. (15.20%), Vaxart, Inc. (6.48%), Cassava Sciences, Inc. (22.91%), Coya Therapeutics, Inc. (2.05%), Kyverna Therapeutics, Inc. (13.20%), C4 Therapeutics, Inc. (9.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short NanoViricides stock? Short selling NNVC is an investing strategy that aims to generate trading profit from NanoViricides as its price is falling. NNVC shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NanoViricides? A short squeeze for NanoViricides occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NNVC, which in turn drives the price of the stock up even further. How often is NanoViricides' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NNVC, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies BDTX Short Interest Data NMRA Short Interest Data ATOS Short Interest Data PROC Short Interest Data SGMT Short Interest Data VXRT Short Interest Data SAVA Short Interest Data COYA Short Interest Data KYTX Short Interest Data CCCC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:NNVC) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NNVC Stock Free NNVC Stock Alerts